The treatment landscape of metastatic renal cell carcinoma (RCC) has been revolutionized
over the past two decades, bringing forth an era in which more than a dozen therapeutic …

CONTEXT: The natural history of renal cell carcinoma (RCC) is highly unpredictable. Small
renal masses may be accompanied by metastatic disease. Conversely, patients with locally …

Purpose: Selecting patients with metastatic clear-cell renal cell carcinoma (m-ccRCC) who
might benefit from treatment with targeted tyrosine kinase inhibitors (TKI) is a challenge. Our …

Clear cell renal cell carcinoma (ccRCC) is the most common form of kidney cancer, but a
comprehensive description of its genomic landscape is lacking. We report the whole …

Kidney cancer is not a single disease; it is made up of a number of different types of cancer,
including clear cell, type 1 papillary, type 2 papillary, chromophobe, TFE3, TFEB, and …

PURPOSE: We investigated the prognostic significance of the neutrophil-to-lymphocyte ratio
to predict recurrence in patients with nonmetastatic renal cell carcinoma. MATERIALS AND …

Abstract The International Society of Urological Pathology convened a consensus
conference on renal cancer, preceded by an online survey, to address issues relating to the …

CONTEXT: The clinical management of patients with renal cell carcinoma (RCC) remains
difficult, and the development of new diagnostic, prognostic, and therapeutic tools is still …

Renal tumor heterogeneity studies have utilized the von Hippel-Lindau VHL gene to classify
disease into molecularly defined subtypes to examine associations with etiologic risk factors …

Renal cell carcinomas (RCC) are emerging as a complex set of diseases that are having a
major socioeconomic impact and showing a continued rise in incidence throughout the …